Task: Answer Verification
Input (English): Question: Does four-day antithrombin therapy seem to attenuate hypercoagulability in patients suffering from sepsis?
Answer: The current study shows a distinct hypercoagulability in patients suffering from severe sepsis, which was not reversed by high-dose AT treatment over four days. This finding supports recent data showing that modulation of coagulatory activation in septic patients by AT does not occur before one week of therapy.
Output (English): no